17% of survey complete.
Dear colleagues,

On behalf of the CMWP of the EBMT, we would like to have your attention for a study to improve the MDS registry data quality.

We would like to study i.e. the impact of the response to pre-graft treatment as a risk factor for post-transplant survival, the risk factors which influence overall survival after allogeneic transplant from a HLA haplo-identical donor and investigate other risk factors associated with outcome in adult MDS patients who received an allogeneic transplantation with PB or BM between the years 2003-2014.

This data quality initiative gives the opportunity to improve the quality of the MDS registry data by completion of important missing MED-B data.

We kindly ask you if you would like to participate in this study.

Thank you very much.

PI: Marie Robin